chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ANXIOUS; TEARFUL; COUGH; NOT FEELING WELL; UNUSUAL SIDE EFFECTS; HAVE NOT EATEN SINCE MONDAY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 29-NOV-2021 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow up to request batch/lot numbers. No concomitant medications were reported. On 29-NOV-2021, the patient experienced unusual side effects. On 29-NOV-2021, the patient experienced have not eaten since monday. On 29-NOV-2021, the patient experienced not feeling well. On an unspecified date, the patient experienced anxious, tearful, and cough. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the not feeling well, unusual side effects, have not eaten since monday, anxious, cough and tearful was not reported. This report was non-serious.
Approximately 5-10 minutes after I received the injection, I was looking at my phone and started to get very dizzy, felt faint, and my heartrate spiked rapidly. My watch noted my heart rate jumped to 130bpm. After working through a few breathing exercises, my heartrate dropped to a resting rate of about 80bpm for the next 20 minutes.
- noticed rapid hair loss, flaking, and bald spots on scalp about a month after 2nd dose - dermatologist diagnosed it as Alopecia areata and prescribed Clobetasol Propionate as a topical treatment - some hair growth in certain spots, but overall, the condition has exacerbated and there are more bald spots and hair loss
Moderate reaction including dizziness, nausea, paleness, muscle aches and bad headache.  No treatment.  8/18/2013 symptoms continued and 8/19/13 started to subside.
Patient tested positive for COVID 19 on 8/27/2021. Patient hospitalized 11/26/2021 and expired 11/29/2021.
sepsis; Inflammatory; Faint; Cold; lightheaded; extreme pain; no movement in the right arm; Arm goes numb at night; shoulder pain; This case was reported by a lawyer and described the occurrence of sepsis in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The initial information received via Medical record on 27 May 2021: the patient received Shingrix vial Kit Pharmacy in the Right arm on 02 Oct 2019, one hour after the shot the arm was getting really sore, and was having a hard lifting or moving right arm. Lunch time he noticed that he was becoming faint, hot then cold, then lightheaded. He thought it was linked to a heart catheter he got implanted about 2 weeks ago, went to Medical Center and they took him right in. They could not get a pulse in the right arm or in finger, and sent him to hospital in ambulance. Now he has no movement in the right arm, extreme pain, at the hospital he was admitted, he got sepsis diagnosis after 3 days. Arm was still sore, and he got a cat scan, sonogram, and a bunch of other tests as well. Arm was currently sore, arm goes numb at night, no rash. They gave the shot all the way up in the shoulder not in muscle and doctors felt it might have penetrated tissue or the rotator cuff. He reported this to pharmacy and they reported it to staff and they asked if he was going to file a claim. They only gave diagnosis of Sepsis on shoulder, also had shoulder pain. He had copies of the shot lot number and all that information. On 21 Nov 2019, he had experienced inflammatory.
Injection given at annual physical on 8/13/12 chills started on 8/13 evening. Temp 101.2 on 8/14/12 AM. Neck stiff and sore all over. Site OK, no itching. 8/14 Temp up to 102. 8/15 temp normal no joint pain & temp normal. Patient stated she thinks she got a little sick when she had shots to go overseas.
Large red, circular/oval mark on arm around injection site that was extremely itchy for about 12 hours.
Patient complained that her left arm hurt, the injection site was red and warm to touch. She also had a knot where the injection was. Her whole arm hurt. She also said that she felt like she had the flu. She had body aches and felt weak for 3 days.
This initial spontaneous report as received from a lawyer regarding a case in litigation refers to a female patient of unknown age. The patient's medical history, concurrent conditions, and concomitant medications were not provided. On 24-OCT-2007, the patient was vaccinated with ZOSTAVAX (dose, route, and lot number not provided) as recommended for routine adult health maintenance and for the long-term prevention of shingles. The vaccine did not prevent shingles as intended and, on an unspecified date, the patient contracted a persistent strain of herpes zoster. On or about 23-FEB-2013, the patient was treated for the onset of a vesicular rash which was diagnosed as severe herpes zoster. The patient was prescribed VALTREX for management of her painful symptoms and chronic pain. As a direct and proximate result of ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering, and other damages. The outcome of vaccination failure and herpes zoster was unknown. The reporter considered vaccination failure and herpes zoster to be related to ZOSTAVAX. Additional information has been requested.
No adverse effects reported.; an unspecified number of patients received improperly stored dose of RECOMBIVAX, GARDASIL 9, MMRII, or PROQUAD; The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify.  Follow-up information has been received from the practice manager on 18-SEP-2018.  This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided.       On 19-JUL-2018, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant Human albumin) (strength and route were unknown) (lot# N024562 and expiration date 06-MAR-2019) for prophylaxis (Incorrect product storage). The sterile diluent (MERCK STERILE DILUENT) was properly stored. No adverse event was reported.  The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001959:
Community member recieved second dose of vaccine within 17 days of first dose Pfizer.
Information was received from a healthcare professional regarding a patient who received no therapy and experienced more pain after receiving PREVNAR than reported with receipt of MMR vaccine. The patient experienced more pain after receiving PREVNAR than reported with receipt of MMR vaccine. Patient's receiving PREVNAR 13, report a pain threshold of 9 or 10 out of 10 compared to 5 out of 10 for MMR vaccine. No outcome was reported. The reporter was unable to specify the number of patient's who experienced this event. Additional reports will be generated when identifying information is provided. No additional information was available at the time of this report. See related case(s): US-WYE-H15453010 (adverse event, non-expedited).
Rash about 6 inches across, pain, swelling, heavy itching, lump under skin, warmth, nausea. Nausea and most pain subsided after a couple of days but the rash is hanging on and it keeps getting itchier.
Head pressure; Light sensitivity; Extreme anxiety; Fatigue; Nausea; Vivid dreams; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 17:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome (POTS), dysautonomia, lyme disease, antiphospholipid syndrome and  sulfonamide allergy (sulfa abx). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Mar2021 at 20:00, the patient experienced head pressure, light sensitivity, extreme anxiety, fatigue, nausea and vivid dreams. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events head pressure, light sensitivity, extreme anxiety, fatigue, nausea and vivid dreams were not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a registered nurse refers to a couple of patients of unknown age. On an unknown date the couple of patients were vaccinated with ZOSTAVAX (lot number not provided). The couple of patients that had a local adverse reaction at the injection site post vaccination with ZOSTAVAX. The site reaction was firm, red, painful, no rash. The reporter did not have the patient's data at the reporting time. The patients had sought unspecified medical attention. The outcome of adverse events was not provided. The causality was not provided. Additional information has been requested.
she "does not do well with vaccines"; left arm was so sore that she could not lift it for 3 days.; left arm was so sore that she could not lift it for 3 days.; This case was reported by a nurse via sales rep and described the occurrence of pain in arm in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   In March 2019, the patient received Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced pain in arm, mobility decreased and feeling unwell. On an unknown date, the outcome of the pain in arm and mobility decreased were recovered/resolved and the outcome of the feeling unwell was unknown.   It was unknown if the reporter considered the pain in arm, mobility decreased and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received shingrix in her left arm was so sore that she could not lift it for 3 days.  The patient was advised to not get the 2nd dose. It was reported that the patient did not do well with vaccines in general including flu.  The reporter did not consented to follow up. The case has been linked with the case US2020AMR175151 reported by same reporter for same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR175151:Same reporter, same patient
Requested patient receive COVID vaccine and patient signed consent form. Upon entering first dose pfizer vaccine into links discovered patient had previously received Moderna series on 04/30/2021 and 05/28/2021. Patient had no adverse event in time monitored post vaccination.
Body aches Headache Period came 3 days early (within 30 hours of vaccine) and heavier flow
This spontaneous report as received from a physician via company representative refers to a 19 year old female patient (not pregnant). The patient's medical history included cancer and chemotherapy on three separate occasions. On an unspecified date, the physician administered MMR II subcutaneously (dose, lot#, expiration date not reported) to a patient. Then, on an unknown date, when the physician checked titers, the patient had no immunity to the measles, mumps and rubella. No concomitant therapy was reported. The outcome of event was unknown. The relatedness between event and MMR II was not reported. Additional information has been requested.
Pfizer lot #FJ6369 with temp excursion. Reported to Pfizer company and ok'd for use. Instructed by staff to report each dose given in this system.
She received Tdap, Hep B & Hep A on 12/20/11. However stated aching the same day but no redness or lumps. She stated elevated fever of 102.3 for 3 days. Both arms ached or so much she couldn't move them. She took VICODIN & TYLENOL/ibuprofen for 10 days, at ER they gave her steroid shot & antibiotic for laryngitis in the 10th day.
I started having sudden double vision. I see things in two. Starting the next day I had light sensitivity. I couldn't open my eyes in the sun or with oncoming headlights. Whenever the sun is out I can't open my eyes. I have been to the eye doctors, and they prescribed me some glasses with prisms in it for my double vision. It helps for when I am out and about driving. I don't have any computer vision glasses. When I went to ER they tested me for a stroke but that was negative. They did say that they saw a small white patch in my brain but that it's not related to the eye issue at all. The issues with my eyes has been constant ever since it happened. I was advised not to take the booster.
chills; fatigue; odd sensation (unsure if related) as if lips were sunburned. (They were not).; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0162) via an unspecified route of administration in the left arm on 21Apr2021 at 09:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any relevant medical history and known allergies. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 21:45, 12 hours after vaccination, the patient experienced chills. On an unspecified date in Apr2021, the patient experienced fatigue. On an unspecified date in 2021, the patient experienced odd sensation (unsure if related) as if lips were sunburned. (They were not). Started after vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills was resolved on an unknown date in Apr2021, while that of fatigue was resolved on an unknown date in 2021, and unsure if related, odd sensation as if lips are sunburned. (They are not.)  was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Induration / erythema 10cm x 4cm. Given Benadryl 50mg.
Itchy Hives all over that last for about 15 min then go away. I would break out in hives any time there was friction on my skin.  Taking levocetirizine, 2 pills calmed it for 24hrs.   Feb 10, 2022, I'm still having to take 1 antihistamine every 48 hours to combat the itching. The condition has calmed down, but hard scratches will cause major the site to inflame and  itch.
Case previously recorded as MA2009-4551. Initial case report received from a nurse, on 18 NOV 2009. A 6 month-old female patient was vaccinated with 0.5 ml of FLUVIRIN 2009/2010 (batch no. 1021261P1A, expiration date 31 MAR 2010) i.m. on 17 NOV 2009, an off-label indication. No adverse event was reported. Reference no: NA09-008426
allergic reactions to many everyday substances.  did not have allergies before. now I have runny nose itching, sneezing all the time.
During the 15 Observation  Patient passed out and fell out of the chair.  Patient was unresponsive for approx 30 seconds.  He had  seizure.   Patient be came alert and responsive confused for about 2 minutes.    After becoming more alert.  Patient stated he has had this happen before when we was giving blood.  Patient had not eaten anything  before coming to get vaccine as well.   911 was called.  BP was 160/80, pulse 60, 02 sat 97% .  Patient refused to go the hospital.  Stated he felt fine now.  I observed him for another hour before letting him leave our facility.
Persistent soreness & discomfort at injection site 5 days after Inj L arm. Asked pt to place ice at site & come to office for follow up. She will go to primary care
Pt received Engerix-B and experienced chronic fatigue syndrome exacerated, fever, unable to sleep, itching over inflamed joints, residual joint aches, joints knees ankles inflamed, all joints painful, muscle pain
Initial intense arm pain. Started sore throat with red lesions/bumps later that day and bilateral arm pain and odd numbness and tingling. Muscle fatigue and overall joint pain started that evening. GI upset. Hot and cold flashes. Sandpaper rash over torso, groin, and back. Extreme fatigue with any effort, then dizziness. Headache, then later severe headache with visual disturbances like tiny colorful lights and later dark spots. Chest pain localized to middle and abdominal pain. Dehydration and lack of appetite until today, 8 days later. Telehealth with family doctor twice, one office visit with normal CBC and ESR according to report on phone. Doctor recommended round the clock Benadryl and ibuprofen. Ruled out strep at a minute clinic to be sure about the rash and sore throat. All are related to the vaccine. No other illness reported. Missed school all week so far.
Diagnosed with vestibular labyrinthitis and otolith dysfunction (100%) to the right ear with permanent damage to the vestibular nerve.  Sudden onset of severe vertigo began approximately 60 hours after administration of shot.  Vertigo caused vomiting.  More than three weeks later, there are lingering symptoms of dizziness.  I have been undergoing vestibular therapy 3 times weekly, and am beginning to imporve.
First dose given 12/18/20 with expected muscle stiffness soreness later that evening and the next day.  Dose two given on 01/07/21 with onset of shaking chills on 01/08/21 at 2:00am, ensuing fever max 101.7 degrees Fahrenheit, at 4:00 am noticed redness of eyes, face flushed with burning feeling, headache, dizziness, blood pressure of 184/96 and heart rate of 153.  This required medical evaluation and treatment with IV fluids and Toradol for resulting headache.  Patient also self administered 1000mg oral Tylenol prior to ER evaluation.
Migraine with aura; Double vision - diplopia; This is a spontaneous report from a contactable consumer, the patient.   A 54-year-old female patient (not pregnant) received the first dose of COVID-19 VACCINE - MANUFACTURER UNKNOWN, administered in arm left, administration date 27Mar2021 (Lot number: unknown) at the age of 54 years as a single dose for COVID-19 immunisation. Relevant medical history included: "Migraine with aura" (unspecified if ongoing) and "Sulfonamide allergy" (unspecified if ongoing), notes: Known allergies: sulpha. There were no concomitant medications. The following information was reported: MIGRAINE WITH AURA (non-serious) with onset 30Mar2021, outcome "recovered with sequelae" on an unknown date in 2021, described as "Migraine with aura"; DIPLOPIA (non-serious) with onset 30Mar2021, outcome "recovered with sequelae" on an unknown date in 2021, described as "Double vision - diplopia". Therapeutic measures were not taken as a result of migraine with aura and diplopia.  Additional Information: The patient did not receive other vaccines within four weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was also reported the patient received the second dose of COVID-19 VACCINE - MANUFACTURER UNKNOWN administered in arm left, administration date 18Apr2021 (Lot number: unknown) at the age of 54 years as a single dose for COVID-19 immunisation.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
In January of 2023 I required for adjustment of anti-hypertension medication. My blood pressure isn't out of control, but it wasn't where they doctor wanted it. I also experienced leg and foot pain at that time. I was given Gabapentin for the pain. I recently had an x-ray of my knee and saw a podiatrist and I think that both pains are explained.
The patient was given her 2nd MMR and within 10-15 minutes her right arm above the injection site was red, swollen and warm to the touch. Ice was applied to the site. There was no previous reaction reported.
I was sick more than two weeks/sick two weeks; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 07-DEC-2020 and additional live follow up on 16-DEC-2020.   This case involves a 60 years old patient of unknown gender who experienced I was sick more than two weeks/sick two weeks (Illness), while he/she received vaccine Influenza Vaccine.   The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, the patient reported So! Total coincidence that the patient only, in 75 years, have had the Flu exactly one time! Age 60 when the patient let the doctor convinced the patient to get the shot because of my age! The patient was sick more than two weeks... only time in life. The patient was sick longer than two days! Never sick since and the patient have a new doctor! The patient thought would skip the privilege! The patient was surrounded by children all the time. 27 grandchildren. Only ones who get sick are the one who get the shots!  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.  The reporter assessed the causal relationship with suspect vaccine as related.
PFIZER-BIONTECH COVID-19 VACCINE EUA.  ADMINISTRATION ERROR- MIXED DOSE SERIES.  Patient reported no prior doses but had received Moderna for 1st dose on 4/15/21 at another clinic.  Notified this would complete vaccine series.  Patient may have been unable to leave nursing facility to get Moderna and would likely have chosen Pfizer due to exceptional circumstance of Moderna not being available to complete the series with the same brand.